Specifically focusing on gastric cancer cases (STAD) within the TCGA, we found a very low frequency of TRIBs genetic and genomic alterations (TRIB1: 9.4%, TRIB2: 2.1%, and TRIB3: 2.1%). The gene discussed is TRIB2; the disease is gastric cancer.